<DOC>
	<DOCNO>NCT02199327</DOCNO>
	<brief_summary>The purpose study evaluate therapeutic efficacy interferon alfa 2b topical mitomycin C patient diagnosis conjunctival-corneal intraepithelial neoplasia .</brief_summary>
	<brief_title>Topical Interferon Alfa 2b Mitomycin C Conjunctival-Corneal Intraepithelial Neoplasia</brief_title>
	<detailed_description>The corneal conjunctival intraepithelial neoplasia common malignant tumor ocular surface . Classic treatment complete excision safety margin , however , usually edge sharp difficult clinical differentiation healthy area ; treatment join carry cryotherapy bed border . Despite treatment recurrence rate range 9-52 % . Antineoplastic drug use either adjuvant primary treatment . Among drug use investigator mitomycin C ( MMC ) interferon alpha 2b ( INFα 2b ) . Controlled clinical trial , single-blind , randomize . Non-probability sample consecutive case . Patients assign treatment MMC INFα2b Periodic clinical evaluation photo make . Time resolution , resistance adverse effect determine . Patients treat mitomycin handle cycle resolution lesion , accord previous study expect 3 6 cycle ( half month 3 month ) . Patients manage interferon treated period range one month 12 month accord clinical resolution lesion . Both group evaluate least one year resolution lesion determine presence recurrence .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Patients clinical diagnosis corneal conjunctival intraepithelial neoplasia ( CIN ) history ocular neoplasia Patients agree participate study . Patients corneal abrasion Patients diagnosis CIN , pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Conjunctival-corneal intraepithelial neoplasia</keyword>
	<keyword>Mitomycin C</keyword>
	<keyword>Interferon alfa 2b</keyword>
</DOC>